nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CA2—collecting duct of renal tubule—retroperitoneal cancer	0.0934	0.0934	CbGeAlD
Imatinib—NTRK1—testis—retroperitoneal cancer	0.0337	0.0337	CbGeAlD
Imatinib—ABCA3—adrenal gland—retroperitoneal cancer	0.0322	0.0322	CbGeAlD
Imatinib—SLC22A1—ganglion—retroperitoneal cancer	0.0322	0.0322	CbGeAlD
Imatinib—DDR1—adrenal gland—retroperitoneal cancer	0.0297	0.0297	CbGeAlD
Imatinib—HIPK4—testis—retroperitoneal cancer	0.027	0.027	CbGeAlD
Imatinib—ABCA3—testis—retroperitoneal cancer	0.0267	0.0267	CbGeAlD
Imatinib—DDR1—testis—retroperitoneal cancer	0.0246	0.0246	CbGeAlD
Imatinib—CA7—kidney—retroperitoneal cancer	0.0236	0.0236	CbGeAlD
Imatinib—ABL2—adrenal gland—retroperitoneal cancer	0.0194	0.0194	CbGeAlD
Imatinib—ABCA3—lymph node—retroperitoneal cancer	0.0193	0.0193	CbGeAlD
Imatinib—PIP4K2C—adrenal gland—retroperitoneal cancer	0.0184	0.0184	CbGeAlD
Imatinib—DDR1—lymph node—retroperitoneal cancer	0.0178	0.0178	CbGeAlD
Imatinib—PTGS1—ganglion—retroperitoneal cancer	0.0175	0.0175	CbGeAlD
Imatinib—NQO2—kidney—retroperitoneal cancer	0.0167	0.0167	CbGeAlD
Imatinib—LCK—adrenal gland—retroperitoneal cancer	0.0163	0.0163	CbGeAlD
Imatinib—ABL2—testis—retroperitoneal cancer	0.016	0.016	CbGeAlD
Imatinib—CA14—adrenal gland—retroperitoneal cancer	0.0159	0.0159	CbGeAlD
Imatinib—SLC22A2—kidney—retroperitoneal cancer	0.0158	0.0158	CbGeAlD
Imatinib—CA12—kidney—retroperitoneal cancer	0.0154	0.0154	CbGeAlD
Imatinib—PIP4K2C—testis—retroperitoneal cancer	0.0152	0.0152	CbGeAlD
Imatinib—CA3—testis—retroperitoneal cancer	0.0145	0.0145	CbGeAlD
Imatinib—CA9—testis—retroperitoneal cancer	0.0139	0.0139	CbGeAlD
Imatinib—NQO2—adrenal gland—retroperitoneal cancer	0.0135	0.0135	CbGeAlD
Imatinib—LCK—testis—retroperitoneal cancer	0.0135	0.0135	CbGeAlD
Imatinib—PDGFRA—adrenal gland—retroperitoneal cancer	0.0134	0.0134	CbGeAlD
Imatinib—SLC47A1—kidney—retroperitoneal cancer	0.0134	0.0134	CbGeAlD
Imatinib—KIT—kidney—retroperitoneal cancer	0.0133	0.0133	CbGeAlD
Imatinib—PDGFRB—kidney—retroperitoneal cancer	0.013	0.013	CbGeAlD
Imatinib—CA1—kidney—retroperitoneal cancer	0.0122	0.0122	CbGeAlD
Imatinib—CSF1R—adrenal gland—retroperitoneal cancer	0.0118	0.0118	CbGeAlD
Imatinib—ABL2—lymph node—retroperitoneal cancer	0.0116	0.0116	CbGeAlD
Imatinib—ABL1—kidney—retroperitoneal cancer	0.0116	0.0116	CbGeAlD
Imatinib—SLC22A1—kidney—retroperitoneal cancer	0.0112	0.0112	CbGeAlD
Imatinib—NQO2—testis—retroperitoneal cancer	0.0112	0.0112	CbGeAlD
Imatinib—PDGFRA—testis—retroperitoneal cancer	0.0111	0.0111	CbGeAlD
Imatinib—PIP4K2C—lymph node—retroperitoneal cancer	0.011	0.011	CbGeAlD
Imatinib—SLC47A1—adrenal gland—retroperitoneal cancer	0.0108	0.0108	CbGeAlD
Imatinib—KIT—adrenal gland—retroperitoneal cancer	0.0108	0.0108	CbGeAlD
Imatinib—CA3—lymph node—retroperitoneal cancer	0.0105	0.0105	CbGeAlD
Imatinib—PDGFRB—adrenal gland—retroperitoneal cancer	0.0105	0.0105	CbGeAlD
Imatinib—CSF1R—testis—retroperitoneal cancer	0.00979	0.00979	CbGeAlD
Imatinib—LCK—lymph node—retroperitoneal cancer	0.00977	0.00977	CbGeAlD
Imatinib—ABL1—adrenal gland—retroperitoneal cancer	0.00936	0.00936	CbGeAlD
Imatinib—SLC47A1—testis—retroperitoneal cancer	0.00894	0.00894	CbGeAlD
Imatinib—KIT—testis—retroperitoneal cancer	0.00889	0.00889	CbGeAlD
Imatinib—PDGFRB—testis—retroperitoneal cancer	0.00868	0.00868	CbGeAlD
Imatinib—ALB—adrenal gland—retroperitoneal cancer	0.00864	0.00864	CbGeAlD
Imatinib—NQO2—lymph node—retroperitoneal cancer	0.00808	0.00808	CbGeAlD
Imatinib—PDGFRA—lymph node—retroperitoneal cancer	0.00806	0.00806	CbGeAlD
Imatinib—CA2—kidney—retroperitoneal cancer	0.00788	0.00788	CbGeAlD
Imatinib—ABL1—testis—retroperitoneal cancer	0.00774	0.00774	CbGeAlD
Imatinib—ALB—testis—retroperitoneal cancer	0.00714	0.00714	CbGeAlD
Imatinib—CSF1R—lymph node—retroperitoneal cancer	0.0071	0.0071	CbGeAlD
Imatinib—CYP3A5—kidney—retroperitoneal cancer	0.00678	0.00678	CbGeAlD
Imatinib—SLC47A1—lymph node—retroperitoneal cancer	0.00648	0.00648	CbGeAlD
Imatinib—KIT—lymph node—retroperitoneal cancer	0.00645	0.00645	CbGeAlD
Imatinib—CA2—adrenal gland—retroperitoneal cancer	0.00637	0.00637	CbGeAlD
Imatinib—PDGFRB—lymph node—retroperitoneal cancer	0.0063	0.0063	CbGeAlD
Imatinib—PTGS1—kidney—retroperitoneal cancer	0.00609	0.00609	CbGeAlD
Imatinib—ORM1—lymph node—retroperitoneal cancer	0.00591	0.00591	CbGeAlD
Imatinib—ABCG2—adrenal gland—retroperitoneal cancer	0.0059	0.0059	CbGeAlD
Imatinib—CA1—lymph node—retroperitoneal cancer	0.0059	0.0059	CbGeAlD
Imatinib—ABL1—lymph node—retroperitoneal cancer	0.00561	0.00561	CbGeAlD
Imatinib—CA2—testis—retroperitoneal cancer	0.00527	0.00527	CbGeAlD
Imatinib—ALB—lymph node—retroperitoneal cancer	0.00518	0.00518	CbGeAlD
Imatinib—CYP3A4—kidney—retroperitoneal cancer	0.00509	0.00509	CbGeAlD
Imatinib—CYP2D6—kidney—retroperitoneal cancer	0.00501	0.00501	CbGeAlD
Imatinib—PTGS1—adrenal gland—retroperitoneal cancer	0.00492	0.00492	CbGeAlD
Imatinib—ABCG2—testis—retroperitoneal cancer	0.00488	0.00488	CbGeAlD
Imatinib—PTGS1—testis—retroperitoneal cancer	0.00407	0.00407	CbGeAlD
Imatinib—CA2—lymph node—retroperitoneal cancer	0.00382	0.00382	CbGeAlD
Imatinib—ABCB1—kidney—retroperitoneal cancer	0.0036	0.0036	CbGeAlD
Imatinib—ABCG2—lymph node—retroperitoneal cancer	0.00354	0.00354	CbGeAlD
Imatinib—CYP2D6—testis—retroperitoneal cancer	0.00335	0.00335	CbGeAlD
Imatinib—PTGS1—lymph node—retroperitoneal cancer	0.00295	0.00295	CbGeAlD
Imatinib—ABCB1—adrenal gland—retroperitoneal cancer	0.00291	0.00291	CbGeAlD
Imatinib—ABCB1—testis—retroperitoneal cancer	0.00241	0.00241	CbGeAlD
Imatinib—ABCB1—lymph node—retroperitoneal cancer	0.00174	0.00174	CbGeAlD
